Both in Biotechnology
Creative Medical Technology Holdings vs Intensity Therapeutics
Over the past year CELZ returned −87.1% and INTS returned −46.3%; their daily moves had a correlation of -0.05.
CELZ −87.1% INTS −46.3%Growth of $1, one year, split-adjusted
| Metric | CELZ | INTS |
|---|---|---|
| Price | $0.7200 | $3.38 |
| Market cap | $5.5M | $11.0M |
| Today | +4.32% | +6.29% |
| 1 month | −25.4% | −1.2% |
| 6 months | −67.6% | −34.4% |
| Year to date | −63.3% | −67.0% |
| 1 year | −86.0% | −44.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 1,822.2× | — |
| Net cash | $8.7M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 145.2% | 62.5% |
| Short % of float | 2.2% | 2.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).